A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques
- 30 June 2006
- journal article
- research article
- Published by Elsevier BV in Virology
- Vol. 353 (1), 166-173
- https://doi.org/10.1016/j.virol.2006.05.005
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a Balanced, Broad, and Protective Neutralizing Antibody Response against Each of the Four Serotypes in Rhesus MonkeysJournal of Virology, 2005
- Chimeric Co-stimulatory Molecules That Selectively Act through CD28 or CTLA-4 on Human T CellsPublished by Elsevier BV ,2002
- Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent VaccineJournal of Virology, 2001
- Japanese Encephalitis and Dengue VaccinesBiologicals, 1997
- Yellow Fever VaccinesBiologicals, 1997
- Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virusArchiv für die gesamte Virusforschung, 1996
- A Live Attenuated Dengue-L Vaccine Candidate (45AZ5) Passaged In Primary Dog Kidney Cell Culture Is Attenuated And Immunogenic For HumansThe Journal of Infectious Diseases, 1994
- Evaluation of vero cell lysate antigen for the ELISA of flavivirusesJournal of Clinical Laboratory Analysis, 1993
- Pathogenesis of Dengue: Challenges to Molecular BiologyScience, 1988
- Antibody-enhanced dengue virus infection in primate leukocytesNature, 1977